CDG Invest Growth exits Techniques Science-Santé (T2S)

14 décembre 2021

CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund.

CDG Invest Growth acquired a significant minority stake in T2S in June 2016 through the Capmezzanine II fund.

Founded in 1992 by Mr. Abderraouf Sordo and his four partners, T2S has become, in less than three decades, the undisputed leader in the distribution and maintenance of medical equipment in Morocco and then in French-speaking Africa, with revenues of around 700 Mdhs in 2020. T2S’s success is the result of long-standing relationships with leading medical device manufacturers, as well as the trust and legitimacy it enjoys with its customers.

Click here for more information about T2S

October 1, 2017

CDG Invest Growth successfully exits Jet Contractors at a 3.3 money multiple

With an investment return of 3.3 money multiple, CDG Invest Growth has announced its total exit from Jet Contractors through a sale of shares on the Casablanca Stock Exchange. “CDG Invest Growth has contributed to the organic and structural development of Jet Contractors and has supported its integration of the value chain to become one […]

January 27, 2023

CDG Invest Growth exits Steripharma, a pharmaceutical business in Morocco

CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale. Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for […]

December 1, 2021